Search
for
Sort by
Research 421–450 of 1000+
- Postmenopausal virilization after spousal use of topical androgens
- Antiandrogen Therapy for Skin and Hair Disease
- What is the Rationale for Androgen Therapy for Women?
- Novel inhibitors of 5α-reductase
- Optimized polycystic ovarian disease prognosis and classification using AI based computational approaches on multi-modality data
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Topical use of systemic drugs in dermatology: A comprehensive review
- Assessment, diagnosis and treatment of a patient with hirsutism
- Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome
- COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily
- Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study
- Dietary vitamin A regulates wingless-related MMTV integration site signaling to alter the hair cycle
- Skin and glucocorticoids: effects of local skin glucocorticoid impairment on skin homeostasis
- Genetic basis of polycystic ovary syndrome
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Relations between sex hormone level and characters of hair and skin in healthy young men
- Treatment of androgenic disorders with dexamethasone: Dose-response relationship for suppression of dehydroepiandrosterone sulfate
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Polycystic Ovarian Syndrome in Adolescents
- Selenium and Polycystic Ovary Syndrome; Current Knowledge and Future Directions: A Systematic Review
- Managing polycystic ovary syndrome in primary care
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- Observation of phenotypic variation among Indian women with polycystic ovary syndrome (PCOS) from Delhi and Srinagar
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature